← Back to headlines
Biogen's High-Dose Spinraza Regimen Approved by FDA
Biogen has received approval from the U.S. Food and Drug Administration for its high-dose Spinraza regimen, a treatment for spinal muscular atrophy.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Cyclospora Outbreak Linked to Iceberg Lettuce Expands to Three Additional States
2h ago
Australian Woman Gives Birth to Twins Fathered by Two Different Men
4h ago
U.S. FDA Approves Landmark Pancreatic Cancer Drug With Improved Survival Rates
8h ago
West Nile Virus Outbreaks Spread Across Greece and North Macedonia
9h ago